Related Experiment Videos
The white blood cell count and risk for coronary heart disease
Insights
Elevated white blood cell (WBC) counts predict coronary heart disease (CHD). Abnormal leukocyte function may drive atherosclerosis and myocardial ischemia, suggesting WBCs play a key role in vascular injury.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Immunology
Background:
- Epidemiologic studies consistently identify elevated white blood cell (WBC) counts as a significant independent predictor of future coronary heart disease (CHD).
- The precise role of WBCs in the pathogenesis of ischemic heart disease remains under investigation, with ongoing debate regarding whether elevated counts are a cause or consequence.
Purpose of the Study:
- To explore the pathophysiologic role of white blood cells, particularly neutrophils, in the development of myocardial ischemia and vascular injury.
- To investigate the potential of leukocyte function as a biomarker and contributing factor in the progression of atherosclerosis.
Main Methods:
- Review of existing epidemiologic data linking WBC counts to CHD incidence.
- Analysis of recent pathophysiologic studies examining leukocyte function in myocardial ischemia.
- Consideration of the implications of abnormal leukocyte function in the context of atherosclerotic disease progression.
Main Results:
- White blood cell count is a strong independent predictor of future coronary heart disease.
- Pathophysiologic evidence suggests neutrophils are instrumental in the pathogenesis of myocardial ischemia.
- Abnormal leukocyte function may precede acute myocardial ischemia, fostering atherosclerotic progression.
Conclusions:
- Quantitative and qualitative changes in leukocyte function are implicated in the development of CHD.
- Further research is needed to fully elucidate WBC properties and the role of activated neutrophils in vascular injury.
- Understanding leukocyte function is crucial for clarifying the mechanisms underlying CHD development.
Abstract:
In conclusion, the WBC count has been demonstrated in several epidemiologic studies to be a strong independent predictor of future coronary heart disease. Although it is not possible at this point in time to be certain that the elevated WBC count is a cause rather than a consequence of ischemic heart disease, recent pathophysiologic studies suggest that the white blood cell, in particular the neutrophil, is instrumental in the pathogenesis of myocardial ischemia. It is conceivable that patients who develop acute myocardial ischemia have abnormal leukocyte function before the onset of the acute event, which provides a pathophysiologic milieu for the progression of the atherosclerotic process. Future research must focus on further elucidation of the properties of WBCs and clarification of the role of the activated neutrophil in the process of vascular injury. Quantitative and qualitative changes in leukocyte function may have important implications in the development of CHD.